![]() |
|||||||||||||||||
![]() |
|||||||||||||||||
![]() ![]() ![]() |
![]() |
|
|||||||||||||||
![]() |
![]() |
MATERIAL SAFETY DATA SHEET - INFECTIOUS SUBSTANCES SECTION I - INFECTIOUS AGENT NAME: Cryptosporidium parvum SYNONYM OR CROSS REFERENCE: Cryptosporidiosis CHARACTERISTICS: Coccidian protozoa; sporozoa; sexual and asexual cycles in a single host; sporozoites, trophozoites and merozoites all attach to epithelial cells (generally intestinal cells); mature oocyst contains 4 thin, flat motile sporozoites (2-4 by 6-8µm) SECTION II - HEALTH HAZARD PATHOGENICITY: Characterized by profuse, watery diarrhea, cramping, abdominal pains, weight loss, anorexia, flatulence and malaise; nausea, vomiting, fever and myalgias may also be present; symptoms are self-limiting in healthy individuals; immunocompromised patients including AIDS patients may experience prolonged symptoms with increasing severity EPIDEMIOLOGY: Worldwide; rate of infection ranges from 1 to 4.5% in developed countries and from 3 to 20% in developing countries; higher infection rates reported in AIDS patients (3-20% in US, 50-60% in Africa and Haiti); frequent outbreaks in daycare centres HOST RANGE: Vertebrates including humans, poultry, fish, reptile, small and large mammals INFECTIOUS DOSE: ID50=132 organisms (N Engl J Med 1995; 332:855-9) MODE OF TRANSMISSION: Fecal-oral route (person-to-person, animal-to-person, food and waterborne transmission) INCUBATION PERIOD: 1 to 12 days; average is 7 days COMMUNICABILITY: Oocysts, the infectious stage, excreted in stools from onset of symptoms to several weeks after symptoms resolve SECTION III - DISSEMINATION RESERVOIR: Humans, cattle and other domestic animals ZOONOSIS: Yes - acquired through contact with contaminated animal fecal matter, particularly diarrhea VECTORS: None SECTION IV - VIABILITY DRUG SUSCEPTIBILITY: No effective therapeutic agent available; cyclosporine inhibits Cryptosporidium growth in vitro SUSCEPTIBILITY TO DISINFECTANTS: Resistant to most disinfectants including 3% hypochlorite, iodophors, 5% formaldehyde; prolonged treatment (18 hours) with 5% ammonia, 10% formol saline (formaldehyde plus sodium chloride) or 3% hydrogen peroxide reduces infectivity PHYSICAL INACTIVATION: Heating at 65°C for 30 minutes reduces infectivity SURVIVAL OUTSIDE HOST: Oocysts may survive for 2 to 6 months in a moist environment SECTION V - MEDICAL SURVEILLANCE: Monitor for symptoms; confirm by microscopic examination of specimens, identification of oocysts in fecal smears FIRST AID/TREATMENT: Administer supportive therapy and rehydration in normal individuals; spiramycin may decrease diarrheal symptoms in early infections; paromomycin has been effective in AIDS patients IMMUNIZATION: None available PROPHYLAXIS: None available SECTION VI - LABORATORY HAZARDS LABORATORY-ACQUIRED INFECTIONS: One case was reported in 1983 due to accidental inoculation; although not documented, infections are thought to occur regularly in all laboratories working with this organism (BMBL, 4th ed., 1999) SOURCES/SPECIMENS: Feces, intestinal biopsy sections PRIMARY HAZARDS: Ingestion; accidental parenteral inoculation; airborne transmission is also possible SPECIAL HAZARDS: Naturally and experimentally infected animals pose a risk to laboratory and animal care personnel SECTION VII - RECOMMENDED PRECAUTIONS CONTAINMENT REQUIREMENTS: Biosafety level 2 practices, containment equipment and facilities for all activities involving known or potentially infectious materials PROTECTIVE CLOTHING: Laboratory coat; gloves when skin contact with infectious materials is unavoidable and when working with animals OTHER PRECAUTIONS: Maintain good personal hygiene and frequent handwashing SECTION VIII - HANDLING INFORMATION SPILLS: Allow aerosols to settle; wearing protective clothing, gently cover spill with absorbent paper towel and apply 10% formol saline or 5 % ammonia, starting at the perimeter and working towards the centre; allow sufficient time (approximately 20 hours) before clean up DISPOSAL: Decontaminate all wastes before disposal; steam sterilization, chemical disinfection, incineration STORAGE: In sealed container that are appropriately labelled SECTION IX - MISCELLANEOUS INFORMATION Date prepared: August 2002 Prepared by: Office of Laboratory Security, PHAC Although the information, opinions and recommendations contained in this Material Safety Data Sheet are compiled from sources believed to be reliable, we accept no responsibility for the accuracy, sufficiency, or reliability or for any loss or injury resulting from the use of the information. Newly discovered hazards are frequent and this information may not be completely up to date. Copyright © [Material Safety Data Sheets - Index]
|
![]() |
|||
![]() |
Last Updated: 2002-08-19 | ![]() |